COPD,heartfailure – MashupMD

Mashup Score: 4

Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Type 2 Diabetes - 10 hour(s) ago

This comparative effectiveness research study examines the outcomes of treatment with sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, or dipeptidyl peptidase-4 inhibitors for patients with type 2 diabetes and chronic obstructive pulmonary disease.

Source: jamanetwork.com

Categories: General Medicine News, Cardiologists

Tweet Tweets with this article
- cpgale3
  
  Interesting observational study, but does anyone know of the (plausible) biological mechanism for SGL2Ti effect on reducing #COPD exacerbations? 🤔, could it be though co-existent #heartfailure ? https://t.co/cs7ma0VOoQ

Mashup Score: 44

Characteristics, treatments and 1‐year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long‐Term Registry - 1 year(s) ago

Aims To describe the characteristics and assess the 1-year outcomes of hospitalized (HHF) and chronic (CHF) heart failure patients with chronic obstructive pulmonary disease (COPD) enrolled in a lar…

Source: onlinelibrary.wiley.com

Categories: General Medicine News, Cardiologists

Tweet Tweets with this article
- cpgale3
  
  In the era of ‘multiple long term conditions’ think about this: #COPD & #heartfailure frequently coexist, which is associated with under diagnosis, progressive worsening of the prescribing gap between admission & discharge & beyond, & an adverse prognosis https://t.co/8N54vJdlVy